ANLN and cancer: As depicted in Figure 11A–P and Supplementary Figures S8A–G, ANLN expression was significantly associated with different immune subtypes of 23 cancers and in BLCA, BRCA, ESCA, LIHC, LUAD, LUSC, MESO, OV, PAAD, PRAD, SARC, SKCM, STAD, UCEC, HNSC, KIRC, and READ, ANLN expression tended to be relatively higher in C1 (wound healing) and C2 (INF-gamma dominant) immune subtypes.